Assessing ultrasound abnormalities in gout patients
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
This study is trying to see how common and serious ultrasound findings are in adults with gout to better understand how the condition affects their joints and tendons.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Boulogne-Billancourt, APHP) |
| Trial ID | NCT05546593 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the prevalence and severity of ultrasound-detected inflammatory, structural, and deposit lesions in patients diagnosed with gout. Conducted at the Ambroise Paré Hospital, the study includes adult patients who meet the ACR/EULAR 2015 criteria for gout and are able to provide informed consent. Participants will undergo clinical and ultrasound examinations performed by two independent physicians to ensure unbiased results. The findings will help establish a clearer understanding of the impact of gout on joints and tendons.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with gout according to the ACR/EULAR 2015 criteria.
Not a fit: Patients with other chronic inflammatory rheumatic diseases or those without French social insurance may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of gout by providing insights into the extent of joint and tendon damage.
How similar studies have performed: While there have been studies on gout, this specific approach using standardized ultrasound definitions is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria were adult patients with a diagnosis of gout according to ACR/EULAR 2015 criteria and able to give informed consent. Exclusion criteria were the presence of other chronic inflammatory rheumatic diseases and patients without French social insurance. Exclusion Criteria: \-
Where this trial is running
Boulogne-Billancourt, APHP
- Rhumatology department, Ambroise Paré hospital - APHP — Boulogne-Billancourt, Aphp, France (Recruiting)
Study contacts
- Principal investigator: Maria-Antonietta D'AGOSTINO, MD, PhD — Rhumatology department, Ambroise Paré hospital - APHP
- Study coordinator: Maria-Antonietta D'AGOSTINO, MD, PhD
- Email: maria-antonietta.dagostino@aphp.fr
- Phone: +33 01 49 09 56 74
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.